Protein trigger for brain cancer

Tel Aviv University researchers have discovered that the secreted protein LCN2 facilitates the formation of aggressive brain metastases (secondary cancers). In lab tests, reducing LCN2 in the blood halts the advance of the inflammatory process that causes tumors in the brain.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *